HCV核心蛋白与ZEB2的相互作用抑制E-cadherin的表达

刘传丽; 毛金菊; 叶媛媛; 胡琴; 张利军; 陈维贤

doi:10.16016/j.1000-5404.201904168

您当前的位置：

首页 >

文章列表页 >

HCV核心蛋白与ZEB2的相互作用抑制E-cadherin的表达

基础医学 | 更新时间：2026-01-09

- HCV核心蛋白与ZEB2的相互作用抑制E-cadherin的表达
- Hepatitis C virus core protein interacts with zinc finger E-box binding homeobox 2 to inhibit E-cadherin expression
- 第三军医大学学报 2019年41卷第18期页码：1744-1749
- 作者机构：
  
  400010 重庆，重庆医科大学附属第二医院检验科
- 作者简介：
  
  [ 陈维贤，电话:(023)63703244，E-mail:chenweixian75@163.com CHEN Weixian, Tel: 86-23-63703244, E-mail: chenweixian75@163.com
- 基金信息：
  
  国家自然科学基金面上项目(31600135);重庆市卫生健康委员会重点资助项目(20141005)
- DOI：10.16016/j.1000-5404.201904168
  中图分类号： R373.21;R394.3;R341
- 收稿：2019-04-11，
  
  修回：2019-05-23，
  
  纸质出版：2019-09-30
- 稿件说明：
移动端阅览
刘传丽, 毛金菊, 叶媛媛, 等. HCV核心蛋白与ZEB2的相互作用抑制E-cadherin的表达[J]. 第三军医大学学报, 2019,41(18):1744-1749.

Chuanli LIU, Jinju MAO, Yuanyuan YE, et al. Hepatitis C virus core protein interacts with zinc finger E-box binding homeobox 2 to inhibit E-cadherin expression[J]. Journal of Third Military Medical University, 2019, 41(18): 1744-1749.
刘传丽, 毛金菊, 叶媛媛, 等. HCV核心蛋白与ZEB2的相互作用抑制E-cadherin的表达[J]. 第三军医大学学报, 2019,41(18):1744-1749. DOI： 10.16016/j.1000-5404.201904168.

Chuanli LIU, Jinju MAO, Yuanyuan YE, et al. Hepatitis C virus core protein interacts with zinc finger E-box binding homeobox 2 to inhibit E-cadherin expression[J]. Journal of Third Military Medical University, 2019, 41(18): 1744-1749. DOI： 10.16016/j.1000-5404.201904168.

摘要

目的

探讨丙型肝炎病毒(hepatitis C virus，HCV)核心蛋白通过与E盒结合锌指蛋白2(zinc finger E-box binding homeobox 2，ZEB2)相互作用抑制E-cadherin表达的分子机制。

方法

转染HCV核心蛋白真核表达质粒至HepG2细胞，并通过G418筛选构建稳定表达HCV核心蛋白的细胞株，以未转染HCV核心蛋白真核表达质粒的细胞作为对照组，采用RT-PCR和Western blot观测核心蛋白对ZEB2和E-cadherin表达水平的影响；采用荧光素酶报告系统分析核心蛋白对E-cadherin启动子活性的调控作用；通过免疫共沉淀及染色质免疫共沉淀技术检测核心蛋白与ZEB2的相互作用及与E-cadherin启动子的结合情况。

结果

与对照组比较，在表达HCV核心蛋白的HepG2细胞中，E-cadherin的蛋白和mRNA表达水平显著降低(

0.01)，而ZEB2的蛋白和mRNA表达水平明显增加(

0.05)。转染HCV核心蛋白的HepG2细胞中，E-cadherin启动子介导的荧光素酶活性显著降低(

0.01)

当利用RNA干扰技术敲减ZEB2后，E-cadherin启动子介导的荧光素酶活性明显恢复(

0.05

)。免疫共沉淀实验显示，HCV核心蛋白可与ZEB2结合，染色质免疫共沉淀实验表明，HCV核心蛋白增强了ZEB2与E-cadherin启动子的结合。

结论

HCV核心蛋白可增强ZEB2的表达并促进其结合至E-cadherin启动子，从而抑制E-cadherin的表达。

Abstract

Objective

To investigate the molecular mechanism by which hepatitis C virus (HCV) core protein represses the expression of E-cadherin by interacting with zinc finger E-box binding homeobox 2 (ZEB2).

Methods

A HepG2 cell line stably expressing HCV core protein was constructed by transfecting the cells with pCore-3FLAG and G418 screening. The expression levels of ZEB2 and E-cadherin in the transfected cells were examined with RT-PCR and Western blotting

and the promoter activity of E-cadherin was assayed using a dual luciferase system. The interaction of HCV core protein with ZEB2 was detected by immunoprecipitation

and the binding of ZEB2 with E-cadherin promoter was determined by chromatin immuoprecipitation.

Results

Compared with the control cells

the cells transiently and stably expressing HCV core protein both showed significantly decreased expression of E-cadherin (

0.01) and increased ZEB2 expression (

0.05) at both the protein and mRNA levels. HepG2 cells transfected with HCV core protein exhibited obviously lowered luciferase activity driven by E-cadherin promoter (

0.01)

while ZEB2 knockdown by RNA interference partly recovered the luciferase activity (

0.05). Immunoprecipitation results demonstrated that HCV core protein could bind directly to ZEB2. Chromatin immunoprecipitation assay showed that the presence of HCV core protein obviously enhanced the binding of ZEB2 to E-cadherin promoter.

Conclusion

HCV core protein increases the expression of ZEB2 and enhances its binding to E-cadherin promoter

and thus inhibits the expression of E-cadherin.

关键词

Keywords

references

BRAY F, FERLAY J, SOERJOMATARAM I, et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.

TAHERKHANI R, FARSHADPOUR F. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges[J]. World J Hepatol, 2017, 9(33): 1239-1252. DOI: 10.4254/wjh.v9.i33.1239.

IRSHAD M, GUPTA P, IRSHAD K. Molecular basis of hepato- cellular carcinoma induced by hepatitis C virus infection[J]. World J Hepatol, 2017, 9(36): 1305-1314. DOI: 10.4254/wjh.v9.i36.1305.

SEDENO-MONGE V, VALLEJO-RUIZ V, SOSA-JURADO F, et al . Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular car cinoma[J ] . J Biosci, 2017, 42(3): 509-521.

PRIETO-GARCÍA E, DÍAZ-GARCÍA C V, GARCÍA-RUIZ I, et al . Epithelial-to-mesenchymal transition in tumor progression[J ] . Med Oncol, 2017, 34(7): 122. DOI: 10.1007/s12032-017-0980-8.

PEINADO H, OLMEDA D, CANO A. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?[J]. Nat Rev Cancer, 2007, 7(6): 415-428. DOI: 10.1038/nrc2131.

黄英, 蔡雪飞, 张君, 等.用T7噬菌体展示技术筛选HCV核心蛋白的相互作用蛋白[J].第三军医大学学报, 2007, 29(10): 876-878. DOI: 10.3321/j.issn:1000-5404.2007.10.006.

HUANG Y, CAI X F, ZHANG J, et al . Screening of proteins interacting with hepatitis C virus core protein from T7-phage display library[J ] . J Third Mil Med Univ, 2007, 29(10): 876-878. DOI:10.3321/j.issn:1000-5404.2007.10.006.

MAHMOUDVAND S, SHOKRI S, TAHERKHANI R, et al . Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma[J ] . World J Gastroenterol, 2019, 25(1): 42-58. DOI:10.3748/wjg.v25.i1.42.

GIANNELLI G, KOUDELKOVA P, DITURI F, et al . Role of epithelial to mesenchymal transition in hepatocellular carcinoma[J ] . J Hepatol, 2016, 65(4): 798-808. DOI:10.1016/j.jhep.2016.05.007.

BOSE S K, MEYER K, DI BISCEGLIE A M, et al . Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes[J ] . J Virol, 2012, 86(24): 13621-13628. DOI: 10.1128/JVI.02016-12.

TIWARI I, YOON M H, PARK B J, et al . Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels[J ] . Cancer Lett, 2015, 362(1): 131-138. DOI: 10.1016/j.canlet.2015.03.032.

AKKARI L, GRÉGOIRE D, FLOC'H N, et al . Hepatitis C viral protein NS 5 A induces EMT and participates in oncogenic transformation of primary hepatocyte precursors[J ] . J Hepatol, 2012, 57(5): 1021-1028. DOI: 10.1016/j.jhep.2012.06.027..

WONG S H M, FANG C M, CHUAH L H, et al . E-cadherin: Its dysregulation in carcinogenesis and clinical implications[J ] . Crit Rev Oncol Hematol, 2018, 121: 11-22. DOI: 10.1016/j.critrevonc.2017.11.010.

[MAEDA S, NAKAGAWA H. Roles o f E-cadherin in hepatocarcinogenesis[M ] //MAEDA S, NAKAGAWA H, ed. Innovative Medicine. Tokyo: Springer Japan, 2015: 71-77. DOI: 10.1007/978-4-431-55651-0_6 http://dx.doi.org/10.1007/978-4-431-55651-0_6 .

JIANG G B, WEN L, DENG W P, et al . Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB 2 [J ] . Biomed Pharmacother, 2017, 90: 806-812. DOI: 10.1016/j.biopha.2017.03.081..

WONG T S, GAO W, CHAN J Y. Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors[J]. Biomed Res Int, 2014, 2014: 921564. DOI: 10.1155/2014/921564.

FARDI M, ALIVAND M, BARADARAN B, et al . The crucial role of ZEB 2 : From development to epithelial-to-mesenchymal transition and cancer complexity[J ] . J Cell Physiol, 2019, 234(9): 14783-14799. DOI: 10.1002/jcp.28277..

QI S T, SONG Y, PENG Y P, et al . ZEB 2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma[J ] . PLoS ONE, 2012, 7(6): e38842. DOI: 10.1371/journal.pone.0038842..

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

丙型肝炎病毒核心蛋白对Dicer切割功能的影响

HCV核心蛋白氨基酸替换与干扰素应答的关系

丙型肝炎病毒核心蛋白抑制shRNA介导的RNA干扰作用

丙型肝炎病毒核心蛋白对Wnt信号抑制因子SFRPs甲基化修饰的影响

SLC38A1通过促进谷氨酰胺摄取激活PI3K/AKT信号通路驱动肝细胞癌恶性进展